TipRanks
Advertisement
Advertisement
United Therapeutics announces accelerated share repurchase agreement
PremiumThe FlyUnited Therapeutics announces accelerated share repurchase agreement
23d ago
United Therapeutics announces FDA accepted sNDA for Tyvaso
Premium
The Fly
United Therapeutics announces FDA accepted sNDA for Tyvaso
29d ago
United Therapeutics presents data at ESC, ERS Congresses
Premium
The Fly
United Therapeutics presents data at ESC, ERS Congresses
1M ago
Buy Rating Reiterated on United Therapeutics as Diversified Pipeline Offsets Near-Term Headwinds; $660 Price Target Maintained
PremiumRatingsBuy Rating Reiterated on United Therapeutics as Diversified Pipeline Offsets Near-Term Headwinds; $660 Price Target Maintained
2M ago
United Therapeutics price target lowered to $515 from $516 at Morgan Stanley
Premium
The Fly
United Therapeutics price target lowered to $515 from $516 at Morgan Stanley
2M ago
United Therapeutics price target lowered to $677 from $704 at RBC Capital
Premium
The Fly
United Therapeutics price target lowered to $677 from $704 at RBC Capital
2M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―